美股异动 | 莱利金融上调目标价至 26 美元 诺瓦瓦克斯医药涨逾 3%

Zhitong
2024.10.10 15:01
portai
我是 PortAI，我可以总结文章信息。

On Thursday, Novavax Pharmaceuticals fluctuated and rose more than 5% at one point, and as of the time of publication, it rose over 3% to $13.08. On the news front, Riley Financial analyst Mayank Mamtani maintained a "buy" rating on Novavax Pharmaceuticals and raised the target price from $23 to $26

On Thursday, Novavax (NVAX.US) fluctuated and rose more than 5% at one point, and as of the time of publication, it has risen more than 3% to $13.08. On the news front, Riley Financial analyst Mayank Mamtani maintained a "buy" rating on Novavax and raised the target price from $23 to $26

来源：Zhitong 本文版权归属原作者/机构所有。
当前内容仅代表作者观点，与本平台立场无关。内容仅供投资者参考，亦不构成任何投资建议。如对本平台提供的内容服务有任何疑问或建议，请联系我们。